Colon cancer treatment costs 2x more in US than Canada

June 1, 2018

People diagnosed with advanced colon cancer pay twice more per month for treatment in the United States than in Canada, but do not live any longer, researchers said Friday.

Canadian residents of British Columbia paid an average of $6,195 per month, compared to patients in the northwestern US state of Washington who paid $12,345, said the study released at the American Society of Clinical Oncology (ASCO) conference in Chicago.

The two regions are about 700 miles (1,100 kilometers) apart, have similar income levels, and a racial makeup that is mainly white with a significant Asian minority.

Canada has a single payer heath system, while the United States has a mix of private insurance and government-funded health insurance.

"To our knowledge, this is the first study to directly compare treatment cost and use, along with health outcomes, in two similar populations treated in different health care models," said lead author Todd Yezefski, a senior fellow at the Fred Hutchison Cancer Research Center in Seattle, Washington.

The findings "may help us improve care and potentially lower ," he added.

The study tracked 1,622 patients with in British Columbia and 575 in Washington state.

The median age of the patients in Canada was 66, while in the United States it was 60.

More patients in the US (79 percent of those diagnosed) than in Canada (68 percent) opted to undergo the most aggressive treatment available.

Both groups were treated with similar kinds of chemotherapy.

Despite paying about twice as much, US patients lived an average of 21.4 months after diagnosis. Canadian patients lived an average of 22.1 months.

Among those who decided not to pursue treatment, the average survival was 5.4 months in Washington and 6.3 months in British Columbia.

"As oncologists, we see the burden of high costs on patients and their families every day," said ASCO chief medical officer Richard Schilsky.

"This study adds important context to the ongoing national conversation about rising treatment costs."

Explore further: Out-of-pocket costs exceed what many insured cancer patients expect to pay

Related Stories

Out-of-pocket costs exceed what many insured cancer patients expect to pay

August 10, 2017
A third of insured people with cancer end up paying more out-of-pocket than they expected, despite having health coverage, researchers at the Duke Cancer Institute have found.

Small-cell lung cancer patients face barriers to receiving standard-of-care treatment

January 4, 2018
Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the initial management of non-metastatic small-cell lung cancer (SCLC), a large percentage of U.S. patients ...

Study finds significant cost differences between breast cancer chemotherapy regimens

October 10, 2016
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost ...

Many cancer patients skimp on treatment due to cost

October 24, 2017
(HealthDay)—The high cost of cancer care in the United States has led more than one-quarter of patients to cut back on some part of their treatment, a new survey reveals.

Drug costs vary by more than 600% in study of 10 high-income countries

June 12, 2017
In a study of 10 high-income countries with universal health care, costs for prescription drugs in 6 of the largest categories of primary care medicines varied by more than 600%, according to research published in CMAJ (Canadian ...

Study identifies significant cost differences between breast cancer chemotherapy regimens

June 4, 2016
Costs associated with different breast cancer chemotherapy regimens can vary significantly, regardless of effectiveness, according to new research from The University of Texas MD Anderson Cancer Center. Understanding cost ...

Recommended for you

'Druggable' cancer target found in pathway regulating organ size

November 20, 2018
It's known that cancer involves unchecked cell growth and that a biological pathway that regulates organ size, known at the Hippo pathway, is also involved in cancer. It's further known that a major player in this pathway, ...

A study suggests that epigenetic treatments could trigger the development of aggressive tumours

November 20, 2018
A study headed by the Institute for Research in Biomedicine (IRB Barcelona) and published in the journal Nature Cell Biology examined whether the opening of chromatin (a complex formed by DNA bound to proteins) is the factor ...

Redefining colorectal cancer subtypes

November 20, 2018
There is a long-standing belief that colorectal cancer (CRC), which causes some 50,000 deaths in the United States each year, can be categorized into distinct molecular subtypes. In a paper published recently in the journal Genome ...

Proposed cancer treatment may boost lung cancer stem cells, study warns

November 20, 2018
Epigenetic therapies—targeting enzymes that alter what genes are turned on or off in a cell—are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant. Researchers at Boston ...

New drug discovery could halt spread of brain cancer

November 19, 2018
The tissues in our bodies largely are made of fluid. It moves around cells and is essential to normal body function.

A molecule for fighting muscular paralysis

November 19, 2018
Myotubular myopathy is a severe genetic disease that leads to muscle paralysis from birth and results in death before two years of age. Although no treatment currently exists, researchers from the University of Geneva (UNIGE), ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.